The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability

Thomas Billiet, Elien Gevaert, Thomas De Schryver, +2

Biomaterials

Tissue EngineeringEngineeringMedicineBioprintingBiomaterials Design +10

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

Maria Theresa Arias, Niels Vande Casteele, Séverine Vermeire, +11

Clinical Gastroenterology and Hepatology

InflammationAnti-inflammatoryGastroenterologyInfliximab TherapyUlcerative Colitis +3

Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis

Konstantinos Papamichael, Thomas Van Stappen, Niels Vande Casteele, +8

Clinical Gastroenterology and Hepatology

InflammationChronic Inflammatory DiseasesMucosal ImmunologyInfliximab Concentration ThresholdsImmunology +4

A20 controls intestinal homeostasis through cell-specific activities

Lars Vereecke, Sara Vieira‐Silva, Thomas Billiet, +12

Nature Communications

Intestinal HomeostasisAutoimmune DiseaseGut-organ AxisAutoimmunityGut Barrier +4

Characteristics of Skin Lesions Associated With Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

Isabelle Cleynen, Wouter Van Moerkercke, Thomas Billiet, +12

Annals of Internal Medicine

Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab

Konstantinos Papamichael, Oliviane Rivals-Lerebours, Thomas Billiet, +8

Journal of Crohn s and Colitis

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease

Thomas Billiet, Konstantinos Papamichael, Magali de Bruyn, +7

Journal of Crohn s and Colitis

A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease

Thomas Billiet, Erwin Dreesen, Isabelle Cleynen, +5

The American Journal of Gastroenterology

Quantitative Contrasts in the Photopolymerization of Acrylamide and Methacrylamide‐<scp>F</scp>unctionalized Gelatin Hydrogel Building Blocks

Thomas Billiet, Björn Van Gasse, Elien Gevaert, +3

Macromolecular Bioscience

Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience

Thomas Billiet, Isabelle Cleynen, Vera Ballet, +4

Alimentary Pharmacology & Therapeutics